Just nine biotech companies have listed in the US this year, raising a total of $1bn, according to LifeSci Capital, a boutique investment bank. Almost 60 companies did so in the same period last year, tapping investors for $7.4bn. Here is much more from the FT.

The post Capital is drying up for biotech companies appeared first on Marginal REVOLUTION.

      Related StoriesSuccessful People are also Happy and Well-AdjustedChina depredation of the dayIs the NIH still broken?
Tap to copy the Short Url to this post:
One-Stop Business News, backed by Mark Cuban. Free to Use →